4.6 Article

Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1-specific immunotherapy using high-dose CpG adjuvant

期刊

ALLERGY
卷 76, 期 7, 页码 2153-2165

出版社

WILEY
DOI: 10.1111/all.14716

关键词

allergen immunotherapy; biTregs; CpG‐ ODN; Fel d 1; TNFR2

资金

  1. Ministry of Higher Education and Research of Luxembourg through the intramural research program of the Luxembourg Institute of Health
  2. Luxembourg National Research Fund (FNR) through the FNRPRIDE program NEXTIMMUNE for doctoral education [PRIDE/11012546/NEXTIMMUNE]

向作者/读者索取更多资源

This study aims to boost immune tolerance to the major cat allergen Fel d 1 by increasing the anti-inflammatory activity of AIT with the established immunomodulatory adjuvant CpG at a higher dose, and shows that this approach reverts all major hallmarks of cat allergy, with the engagement of pDC-Treg and B-cell axes and the emergence of a biTreg population. The results suggest the potential of CpG adjuvant in inducing allergen-specific tolerance in patients with cat allergy or other allergic diseases.
Background The prevalence of allergy to cat is expanding worldwide. Allergen-specific immunotherapy (AIT) has advantages over symptomatic pharmacotherapy and promises long-lasting disease control in allergic patients. However, there is still a need to improve cat AIT regarding efficacy, safety, and adherence to the treatment. Here, we aim to boost immune tolerance to the major cat allergen Fel d 1 by increasing the anti-inflammatory activity of AIT with the established immunomodulatory adjuvant CpG, but at a higher dose than previously used in AIT. Methods Together with CpG, we used endotoxin-free Fel d 1 as therapeutic allergen throughout the study in a BALB/c model of allergy to Fel d 1, thus mimicking the conditions of human AIT trials. Multidimensional immune phenotyping including mass cytometry (CyTOF) was applied to analyze AIT-specific immune signatures. Results We show that AIT with high-dose CpG in combination with endotoxin-free Fel d 1 reverts all major hallmarks of allergy. High-dimensional CyTOF analysis of the immune cell signatures initiating and sustaining the AIT effect indicates the simultaneous engagement of both, the pDC-Treg and B-cell axis, with the emergence of a systemic GATA3(+) FoxP3(hi) biTreg population. The regulatory immune signature also suggests the involvement of the anti-inflammatory TNF/TNFR2 signaling cascade in NK and B cells at an early stage and in Tregs later during AIT. Conclusion Our results highlight the potential of CpG adjuvant in a novel formulation to be further exploited for inducing allergen-specific tolerance in patients with cat allergy or other allergic diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据